Prior studies41,45 have reported that microglial senescence is more prevalent in AD than in non-diseased brains, supported by increased immunostaining of senescence markers such as β-gal, p16, p21,46 and γH2AX.47 The gene discussed is CDKN1A; the disease is Alzheimer disease.